Showing results (11-20 of 85) with videos related to
Sort By:
Pageof 9
Vascular Health and Risk Management|December 15, 2007
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE) in the management of hemophilia AAmy D ShapiroClinical Advances in Hematology & Oncology : H&O|September 30, 2008
Single-dose recombinant activated factor VII for the treatment of joint bleeds in hemophilia patients with inhibitorsAmy D ShapiroBlood Advances|February 11, 2021
Concizumab: a novel anti-TFPI therapeutic for hemophiliaAmy D ShapiroF1000Research|August 22, 2019
Merging into the mainstream: the evolution of the role of point-of-care musculoskeletal ultrasound in hemophiliaNihal Bakeer, Amy D ShapiroTherapeutic Advances in Drug Safety|August 2, 2014
Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomesAmy D Shapiro, Ulla HednerJournal of Blood Medicine|February 25, 2025
Emerging Therapies in Hemophilia: Improving Equitable Access to CareMagdalena Lewandowska, Sonia Nasr, Amy D ShapiroBlood|February 26, 2015
Rare bleeding disorders: diagnosis and treatmentRoberta Palla, Flora Peyvandi, Amy D ShapiroHaemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2022
Therapeutic and technological advancements in haemophilia care: Quantum leaps forwardMagdalena Lewandowska, Sonia Nasr, Amy D ShapiroEuropean Journal of Haematology|February 19, 2024
Recombinant factor IX Fc for the treatment of hemophilia BRolf Ljung, Davide Matino, Amy D ShapiroPageof 9